| Wissenschaftl. Titel | A Randomized Double-blind, Placebo-controlled Study of LEE011 in Combination With Letrozole for the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease |
| Erkrankung |
Geschlechtsorgane:
Brustkrebs:
Erstlinie
|
| Molekularer Marker |
HER2/neu neg. PR HER2/neu neg./ER pos. ER HER2/neu neg./PR pos. |
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 03.05.2018 Student Studienregister
geändert 26.02.2024 Admin04